JoeY.ChangMDPhD, FASTRO
Radiation Oncology • Houston, TXThoracic Cancer
Texas 4000 Distinguished Professor Director of Stereotactic Ablative Radiotherapy Program Department of Radiation Oncology MD Anderson Cancer Center
Dr. Chang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-563-2337- Is this information wrong?
Summary
- Dr. Chang is a thoracic radiation oncologist with more than 30 years of clinical and research experience. He holds a tenured Texas 4000 Distinguished Professorship at MD Anderson Cancer Center. He is an appointed American Society of Radiation Oncology Fellow and has been recognized with the Best Doctors of America award. He is one of the pioneers in the field of stereotactic ablative radiotherapy (SABR) and proton therapy for lung cancer, having published more than 260 peer-reviewed articles in prestigious journals, including LANCET, Nature, JAMA, Journal of Clinical Oncology, Journal of Thoracic Oncology, and various others. His randomized study comparing surgery vs SABR in operable stage I lung cancer, concurrent proton therapy and chemotherapy in stage III lung cancer, and the implementation of intensity-modulated proton therapy (IMPT) in lung cancer were the first reported clinical studies in the world to do so. His research has helped establish the role of SABR, proton therapy, and combined immunotherapy and SABR (I-SABR) in lung cancer; currently, he is the principle investigator of a randomized study of I-SABR in early stage lung cancer. He is a voting committee member of NCCN thoracic guidelines and chairs both the international proton therapy PTCOG thoracic and American Radium Society Thoracic AUS committees. Additionally, on behalf of national and international societies, Dr. Chang has led several important consensus statements that have significantly impacted in radiation oncology community about SABR, proton therapy in lung cancer, IMPT in moving thoracic cancers, management of small cell lung cancer, oligometastasis, and re-irradiation of thoracic cancer.
Education & Training
Rush University Medical CenterResidency, Radiation Oncology, 1997 - 2002
Shanghai Medical UniversityClass of 1985
Certifications & Licensure
FL State Medical License 2021 - Present
WA State Medical License 2022 - 2025
TX State Medical License 2002 - 2025
TN State Medical License 2022 - 2024
AZ State Medical License 2022 - 2024
GA State Medical License 2022 - 2024
MS State Medical License 2022 - 2024- American Board of Radiology Radiation Oncology
- Join now to see all
Clinical Trials
- SRS Study in Patients With Non-Small Cell Lung Cancer Start of enrollment: 2005 Nov 21
- Proton Radiotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2006 May 04
- Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2006 Apr 14
- Join now to see all
Publications & Presentations
PubMed
- American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non-Small Cell Lung Cancer.George Rodrigues, Kristin A Higgins, Henry S Park, Andrea Wolf, Charles B Simone 2nd, Andreas Rimner, Arya Amini, Joe Y Chang, Stephen G Chun, Jessica Donington, Marti...> ;JAMA Oncology. 2024 Apr 11
- 1 citationsThe Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific Perspectives.Amy J Wisdom, Christopher A Barker, Joe Y Chang, Sandra Demaria, Silvia Formenti, Clemens Grassberger, Fabiana Gregucci, Bradford S Hoppe, David G Kirsch, Ariel E Marc...> ;International Journal of Radiation Oncology, Biology, Physics. 2024 Apr 1
- Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable local...Kelsey L Corrigan, Ting Xu, Yuki Sasaki, Ruitao Lin, Aileen B Chen, James W Welsh, Steven H Lin, Joe Y Chang, Matthew S Ning, Saumil Gandhi, Michael S O'Reilly, Carl M...> ;Radiotherapy and Oncology. 2024 Apr 1
- Join now to see all
Journal Articles
- Time to Abandon Single-Site Irradiation for Inducing Abscopal EffectsJoe Chang, MD, Nature
Press Mentions
Texas Doctor Reflects on the Lessons and Loss in 2021December 28th, 2021- Stereotactic Ablative Radiotherapy Shows Long-Term Benefit in Operable Early NSCLCNovember 23rd, 2021
- Long-Term Benefit of SABR for Operable Early-Stage NSCLC Shown in New StudySeptember 13th, 2021
- Join now to see all
Committees
- Member, Committee on Appropriateness Criteria, Expert Panel on Interventional Radiology, American College of Radiology 2015 - Present
Professional Memberships
- Member
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
